Related Experiment Video
Updated: Oct 21, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based
Stephen G Fung1,2, Richard Webster1, M Ellen Kuenzig1,2,3
1Children's Hospital of Eastern Ontario Research Institute.
Insights
Children with Kawasaki disease (KD) have an increased risk of developing arthritis, but not other immune-mediated inflammatory diseases (IMIDs). Healthcare providers should monitor for arthritis in children after a KD diagnosis.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Epidemiology
Background:
- Kawasaki disease (KD) is a childhood vasculitis causing multi-organ inflammation.
- The risk of subsequent immune-mediated inflammatory diseases (IMIDs) after KD is not fully understood.
Purpose of the Study:
- To determine the risk of IMIDs, including arthritis, type 1 diabetes, IBD, autoimmune liver disease, primary sclerosing cholangitis, and multiple sclerosis, following a KD diagnosis.
Main Methods:
- A population-based cohort study in Ontario, Canada, matched 3753 children with KD to 18749 controls.
- Health administrative data were used to assess IMID incidence after KD resolution, employing 3- and 12-month washout periods.
Main Results:
- An elevated risk of arthritis was observed in KD patients (IRR 8.07) compared to controls.
- Overall IMID incidence was elevated in KD patients (IRR 2.58), primarily driven by arthritis.
- No increased risk for diabetes, IBD, autoimmune liver disease, primary sclerosing cholangitis, or multiple sclerosis was found.
Conclusions:
- Children diagnosed with KD face a higher risk of arthritis post-diagnosis.
- No increased risk for other IMIDs was identified in KD patients.
- Monitoring for arthritis is recommended for children following a Kawasaki disease diagnosis.
Objectives:
Kawasaki disease (KD) is an immune-mediated vasculitis of childhood with multi-organ inflammation. We determined the risk of subsequent immune-mediated inflammatory disease (IMID), including arthritis, type 1 diabetes, IBD, autoimmune liver disease, primary sclerosing cholangitis and multiple sclerosis.
Methods:
We conducted a matched population-based cohort study using health administrative data from Ontario, Canada. Children aged <18 years born between 1991 and 2016 diagnosed with KD (n = 3753) were matched to 5 non-KD controls from the general population (n = 18 749). We determined the incidence of IMIDs after resolution of KD. Three- and 12-month washout periods were used to exclude KD-related symptoms.
Results:
There was an elevated risk of arthritis in KD patients compared with non-KD controls, starting 3 months after index date [103.0 vs 12.7 per 100 000 person-years (PYs); incidence rate ratio 8.07 (95% CI 4.95, 13.2); hazard ratio 8.08 (95% CI 4.95, 13.2), resulting in the overall incidence of IMIDs being elevated in KD patients (175.1 vs 68.0 per 100 000 PYs; incidence rate ratio 2.58 (95% CI 1.93, 3.43); hazard ratio 2.58, 95% CI 1.94, 3.43]. However, there was no increased risk for diabetes, IBD, autoimmune liver disease, primary sclerosing cholangitis or multiple sclerosis in KD patients. Similar results were observed using a 12-month washout period.
Conclusion:
Children diagnosed with KD were at increased risk of arthritis following the acute KD event, but not other IMIDs. Health-care providers should monitor for arthritis in children following a diagnosis of KD.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Rheumatic Heart Disease III: Medical Management

